{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:26:55Z","timestamp":1792099615365,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Polish Cardiac Society"},{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["2024\/55\/D\/NZ4\/01538"],"award-info":[{"award-number":["2024\/55\/D\/NZ4\/01538"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Cardiology, Warsaw, Poland","award":["statutory grant 1.2.17\/VII\/23"],"award-info":[{"award-number":["statutory grant 1.2.17\/VII\/23"]}]},{"name":"National Institute of Cardiology, Warsaw","award":["statutory grant 2.20\/VII\/23"],"award-info":[{"award-number":["statutory grant 2.20\/VII\/23"]}]},{"name":"Agency for Medical Research","award":["KPOD.07.07-IW.07-0149\/24"],"award-info":[{"award-number":["KPOD.07.07-IW.07-0149\/24"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03190-4","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T10:46:08Z","timestamp":1779792368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exerkine dysregulation links visceral adiposity to skeletal muscle impairment in end-stage heart failure with reduced ejection fraction: proteomic evidence for a cardio\u2013adipose\u2013muscle axis"],"prefix":"10.1186","volume":"25","author":[{"given":"Marta","family":"Za\u0142\u0119ska-Koci\u0119cka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Mazuruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Szcze\u015bniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"\u0141aba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Kacperska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Nogajski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksymilian","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"M\u0105czewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Czerwi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0142osz","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Olbry\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"M\u0105czy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Kuriata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ko\u0142sut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Wojdy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Micha\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Paterek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"B\u0142yszczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Leszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"M\u0105czewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"37","key":"3190_CR1","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2023;44(37):3627\u201339.","journal-title":"Eur Heart J"},{"issue":"7","key":"3190_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","volume":"34","author":"S F\u00fclster","year":"2013","unstructured":"F\u00fclster S, Tacke M, Sandek A, Ebner N, Tsch\u00f6pe C, Doehner W, et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J. 2013;34(7):512\u20139.","journal-title":"Eur Heart J"},{"issue":"14","key":"3190_CR3","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/jama.2009.454","volume":"301","author":"CM O'Connor","year":"2009","unstructured":"O\u2019Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439\u201350.","journal-title":"JAMA"},{"issue":"5","key":"3190_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41574-022-00641-2","volume":"18","author":"LS Chow","year":"2022","unstructured":"Chow LS, Gerszten RE, Taylor JM, Pedersen BK, van Praag H, Trappe S, et al. Exerkines in health, resilience and disease. Nat Rev Endocrinol. 2022;18(5):273\u201389.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"3190_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s44321-024-00027-z","volume":"16","author":"L Jin","year":"2024","unstructured":"Jin L, Diaz-Canestro C, Wang Y, Tse MA, Xu A. Exerkines and cardiometabolic benefits of exercise: from bench to clinic. EMBO Mol Med. 2024;16(3):432\u201344.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"3190_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01841-0","volume":"9","author":"D Walzik","year":"2024","unstructured":"Walzik D, Wences Chirino TY, Zimmer P, Joisten N. Molecular insights of exercise therapy in disease prevention and treatment. Signal Transduct Target Ther. 2024;9(1):138.","journal-title":"Signal Transduct Target Ther"},{"key":"3190_CR7","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14855","volume":"11","author":"L Gu","year":"2023","unstructured":"Gu L, Jiang W, Jiang W, Xu Z, Li W, Zhang H. Elevated serum FGF21 levels predict heart failure during hospitalization of STEMI patients after emergency percutaneous coronary intervention. PeerJ. 2023;11:e14855.","journal-title":"PeerJ"},{"issue":"12","key":"3190_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13820","volume":"25","author":"A Paterek","year":"2024","unstructured":"Paterek A, Za\u0142\u0119ska-Koci\u0119cka M, Wojdy\u0144ska Z, Kalisz M, Litwiniuk A, Leszek P, et al. Epicardial fat in heart failure - friend, foe or bystander. Obes Rev. 2024;25(12):e13820.","journal-title":"Obes Rev"},{"key":"3190_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pcad.2023.04.006","volume":"78","author":"G Iacobellis","year":"2023","unstructured":"Iacobellis G. Epicardial fat links obesity to cardiovascular diseases. Prog Cardiovasc Dis. 2023;78:27\u201333.","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"3190_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12933-026-03126-y","volume":"25","author":"M Nowakowski","year":"2026","unstructured":"Nowakowski M, Mazuruk M, Nogajski \u0141, M\u0105czewski M, Czerwi\u0144ska H, Kurpias M, et al. Epicardial adipose tissue as a determinant of heart failure prognosis: insights across ejection fraction phenotypes. Cardiovasc Diabetol. 2026;25(1):99.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3190_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02474-x","volume":"23","author":"\u0141 Nogajski","year":"2024","unstructured":"Nogajski \u0141, Mazuruk M, Kacperska M, Kurpias M, M\u0105czewski M, Nowakowski M, et al. Epicardial fat density obtained with computed tomography imaging - more important than volume? Cardiovasc Diabetol. 2024;23(1):389.","journal-title":"Cardiovasc Diabetol"},{"issue":"13","key":"3190_CR12","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/CIRCULATIONAHA.117.029617","volume":"137","author":"IJ Neeland","year":"2018","unstructured":"Neeland IJ, Poirier P, Despr\u00e9s J-P. Cardiovascular and metabolic heterogeneity of obesity. Circulation. 2018;137(13):1391\u2013406.","journal-title":"Circulation"},{"key":"3190_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ijcard.2016.06.231","volume":"220","author":"T Furihata","year":"2016","unstructured":"Furihata T, Kinugawa S, Fukushima A, Takada S, Homma T, Masaki Y, et al. Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure. Int J Cardiol. 2016;220:483\u20137.","journal-title":"Int J Cardiol"},{"key":"3190_CR14","doi-asserted-by":"crossref","unstructured":"(ATS) ATS: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166(1):111\u2013117.","DOI":"10.1164\/ajrccm.166.1.at1102"},{"key":"3190_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03106-2","author":"M M\u0105czewski","year":"2026","unstructured":"M\u0105czewski M, Za\u0142\u0119ska-Koci\u0119cka M, Nowakowski M, Mazuruk M, Nogajski \u0141, Czerwi\u0144ska H, et al. Epicardial fat remodeling in end-stage heart failure with reduced ejection fraction. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03106-2. (In Press).","journal-title":"Cardiovasc Diabetol"},{"key":"3190_CR16","volume":"13","author":"I Micha\u0142owska","year":"2025","unstructured":"Micha\u0142owska I, M\u0105czewski M, Nowakowski M, Nogajski \u0141, Surzykiewicz M, Za\u0142\u0119ska-Koci\u0119cka M, et al. Left ventricular epicardial fat signature in end-stage heart failure with reduced ejection fraction. JACC: Heart Failure. 2025;13:102647.","journal-title":"JACC: Heart Failure"},{"issue":"1","key":"3190_CR17","doi-asserted-by":"publisher","DOI":"10.2196\/medinform.4923","volume":"4","author":"YJ Kim","year":"2016","unstructured":"Kim YJ, Park JW, Kim JW, Park CS, Gonzalez JP, Lee SH, et al. Computerized automated quantification of subcutaneous and visceral adipose tissue from computed tomography scans: development and validation study. JMIR Med Inform. 2016;4(1):e2.","journal-title":"JMIR Med Inform"},{"issue":"2","key":"3190_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/ajcn\/80.2.271","volume":"80","author":"W Shen","year":"2004","unstructured":"Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, et al. Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr. 2004;80(2):271\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"3190_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2018","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2018;48(1):16\u201331.","journal-title":"Age Ageing"},{"issue":"1","key":"3190_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/eurheartj\/ehaf645","volume":"47","author":"M Packer","year":"2025","unstructured":"Packer M. Do obesity and visceral adiposity promote heart failure with reduced ejection fraction? Eur Heart J. 2025;47(1):12\u201321.","journal-title":"Eur Heart J"},{"issue":"9","key":"3190_CR21","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/ejhf.792","volume":"19","author":"A Olivier","year":"2017","unstructured":"Olivier A, Pitt B, Girerd N, Lamiral Z, Machu J-L, McMurray JJV, et al. Effect of Eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the Emphasis-Hf Trial. Eur J Heart Fail. 2017;19(9):1186\u201397.","journal-title":"Eur J Heart Fail"},{"key":"3190_CR22","doi-asserted-by":"crossref","unstructured":"Di Vincenzo O, Minnetti M, Baker JL, Barazzoni R, Boyland E, Busetto L, Ciudin A, Dicker D, Fabryova L, Helgason T et al:   European association for the study of obesity position statement on the diagnosis and management of obesity in older adults. Obesity Facts 2025.","DOI":"10.1159\/000549751"},{"issue":"4","key":"3190_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5114\/ait.2023.132460","volume":"55","author":"J Walpot","year":"2023","unstructured":"Walpot J, Van Herck P, Van de Heyning CM, Bosmans J, Massalha S, In\u00e1cio JR, et al. Computed tomography measured epicardial adipose tissue and psoas muscle attenuation: new biomarkers to predict major adverse cardiac events and mortality in patients with heart disease and critically ill patients. Part II: psoas muscle area and density. Anaesthesiology Intensive Therapy. 2023;55(4):243\u201361.","journal-title":"Anaesthesiology Intensive Therapy"},{"issue":"10","key":"3190_CR24","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/gerona\/glz034","volume":"74","author":"B Amini","year":"2019","unstructured":"Amini B, Boyle SP, Boutin RD, Lenchik L. Approaches to assessment of muscle mass and myosteatosis on computed tomography: a systematic review. J Gerontol A Biol Sci Med Sci. 2019;74(10):1671\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"3190_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jcsm.12043","volume":"6","author":"TS Bowen","year":"2015","unstructured":"Bowen TS, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle. 2015;6(3):197\u2013207.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"3190_CR26","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1002\/ehf2.15371","volume":"12","author":"W Kawaharata","year":"2025","unstructured":"Kawaharata W, Kouzu H, Ogura K, Yano T, Katano S, Numazawa R, et al. Diagnostic value of computed tomography-based muscle quality and metabolic signatures in heart failure with sarcopenia. ESC Heart Fail. 2025;12(5):3589\u2013600.","journal-title":"ESC Heart Fail"},{"key":"3190_CR27","doi-asserted-by":"publisher","DOI":"10.34133\/research.0832","volume":"8","author":"T Tian","year":"2025","unstructured":"Tian T, Liu M, Little PJ, Strijdom H, Weng J, Xu S. Emerging roles of GDF15 in metabolic and cardiovascular diseases. Research. 2025;8:0832.","journal-title":"Research"},{"key":"3190_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131870","author":"C Laurens","year":"2020","unstructured":"Laurens C, Parmar A, Murphy E, Carper D, Lair B, Maes P, et al. Growth and differentiation factor 15 is secreted by skeletal muscle during exercise and promotes lipolysis in humans. JCI Insight. 2020. https:\/\/doi.org\/10.1172\/jci.insight.131870.","journal-title":"JCI Insight"},{"issue":"2","key":"3190_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/MOL.0000000000001025","volume":"37","author":"D Wang","year":"2026","unstructured":"Wang D, Townsend LK, Steinberg GR. Beyond cellular distress: reframing GDF15 as a lipid-sensitive metabolic signal. Curr Opin Lipidol. 2026;37(2):45\u201351.","journal-title":"Curr Opin Lipidol"},{"key":"3190_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","volume":"78","author":"FM Fisher","year":"2016","unstructured":"Fisher FM, Maratos-Flier E. Understanding the physiology of FGF21. Annu Rev Physiol. 2016;78:223\u201341.","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"3190_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.cmet.2016.05.025","volume":"24","author":"HY Moon","year":"2016","unstructured":"Moon HY, Becke A, Berron D, Becker B, Sah N, Benoni G, et al. Running-induced systemic cathepsin B secretion is associated with memory function. Cell Metab. 2016;24(2):332\u201340.","journal-title":"Cell Metab"},{"issue":"Pt 1","key":"3190_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1113\/jphysiol.2007.139618","volume":"584","author":"AR Nielsen","year":"2007","unstructured":"Nielsen AR, Mounier R, Plomgaard P, Mortensen OH, Penkowa M, Speerschneider T, et al. Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J Physiol. 2007;584(Pt 1):305\u201312.","journal-title":"J Physiol"},{"key":"3190_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-015-0058-2","volume":"5","author":"PL Huang","year":"2015","unstructured":"Huang PL, Hou MS, Wang SW, Chang CL, Liou YH, Liao NS. Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis. Skelet Muscle. 2015;5:33.","journal-title":"Skelet Muscle"},{"issue":"16","key":"3190_CR34","doi-asserted-by":"publisher","first-page":"9306","DOI":"10.1073\/pnas.151270098","volume":"98","author":"SJ Lee","year":"2001","unstructured":"Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A. 2001;98(16):9306\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6628","key":"3190_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC McPherron","year":"1997","unstructured":"McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387(6628):83\u201390.","journal-title":"Nature"},{"issue":"1","key":"3190_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.0.CO;2-V","volume":"180","author":"M Sharma","year":"1999","unstructured":"Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, et al. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol. 1999;180(1):1\u20139.","journal-title":"J Cell Physiol"},{"key":"3190_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0365-0","volume":"13","author":"JA Ba\u00e1n","year":"2015","unstructured":"Ba\u00e1n JA, Varga ZV, Leszek P, Ku\u015bmierczyk M, Baranyai T, Dux L, et al. Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study. J Transl Med. 2015;13:1.","journal-title":"J Transl Med"},{"issue":"3","key":"3190_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.109.882068","volume":"121","author":"J Heineke","year":"2010","unstructured":"Heineke J, Auger-Messier M, Xu J, Sargent M, York A, Welle S, et al. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation. 2010;121(3):419\u201325.","journal-title":"Circulation"},{"issue":"7","key":"3190_CR39","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/eurjhf\/hfr024","volume":"13","author":"D Gruson","year":"2011","unstructured":"Gruson D, Ahn SA, Ketelslegers J-M, Rousseau MF. Increased plasma myostatin in heart failure. Eur J Heart Fail. 2011;13(7):734\u20136.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"3190_CR40","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/eurjhf\/hfq039","volume":"12","author":"I George","year":"2010","unstructured":"George I, Bish LT, Kamalakkannan G, Petrilli CM, Oz MC, Naka Y, et al. Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail. 2010;12(5):444\u201353.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"3190_CR41","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s12020-012-9836-3","volume":"43","author":"HM Christensen","year":"2013","unstructured":"Christensen HM, Kistorp C, Schou M, Keller N, Zerahn B, Frystyk J, et al. Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status. Endocrine. 2013;43(3):626\u201334.","journal-title":"Endocrine"},{"issue":"3","key":"3190_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.11005\/jbm.2020.27.3.151","volume":"27","author":"J Suh","year":"2020","unstructured":"Suh J, Lee YS. Myostatin inhibitors: panacea or predicament for musculoskeletal disorders? J Bone Metab. 2020;27(3):151\u201365.","journal-title":"J Bone Metab"},{"issue":"2","key":"3190_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.tem.2013.10.006","volume":"25","author":"K Marosi","year":"2014","unstructured":"Marosi K, Mattson MP. BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol Metab. 2014;25(2):89\u201398.","journal-title":"Trends Endocrinol Metab"},{"key":"3190_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf024","author":"J Pratt","year":"2025","unstructured":"Pratt J, Motanova E, Narici MV, Boreham C, De Vito G. Plasma brain-derived neurotrophic factor concentrations are elevated in community-dwelling adults with sarcopenia. Age Ageing. 2025. https:\/\/doi.org\/10.1093\/ageing\/afaf024.","journal-title":"Age Ageing"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03190-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03190-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03190-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:30:51Z","timestamp":1784770251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03190-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3190"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03190-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research protocol was approved by the local ethics committee (No. IK.NPIA.0021.28.2026\/23), and written informed consent was obtained from all participants prior to inclusion.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"208"}}